Willow Biosciences Stock Market Value
| CANSF Stock | USD 0.12 0.00 0.00% |
| Symbol | Willow |
Willow Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Willow Biosciences' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Willow Biosciences.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Willow Biosciences on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Willow Biosciences or generate 0.0% return on investment in Willow Biosciences over 90 days. Willow Biosciences is related to or competes with Leef Brands, C21 Investments, and Medical Developments. Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer c... More
Willow Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Willow Biosciences' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Willow Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.48 | |||
| Information Ratio | 0.0485 | |||
| Maximum Drawdown | 35.38 | |||
| Value At Risk | (13.33) | |||
| Potential Upside | 15.38 |
Willow Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Willow Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Willow Biosciences' standard deviation. In reality, there are many statistical measures that can use Willow Biosciences historical prices to predict the future Willow Biosciences' volatility.| Risk Adjusted Performance | 0.0549 | |||
| Jensen Alpha | 0.379 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0389 | |||
| Treynor Ratio | 0.3171 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Willow Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Willow Biosciences February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0549 | |||
| Market Risk Adjusted Performance | 0.3271 | |||
| Mean Deviation | 6.3 | |||
| Semi Deviation | 6.59 | |||
| Downside Deviation | 10.48 | |||
| Coefficient Of Variation | 1760.47 | |||
| Standard Deviation | 8.4 | |||
| Variance | 70.61 | |||
| Information Ratio | 0.0485 | |||
| Jensen Alpha | 0.379 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0389 | |||
| Treynor Ratio | 0.3171 | |||
| Maximum Drawdown | 35.38 | |||
| Value At Risk | (13.33) | |||
| Potential Upside | 15.38 | |||
| Downside Variance | 109.8 | |||
| Semi Variance | 43.43 | |||
| Expected Short fall | (10.88) | |||
| Skewness | 0.1656 | |||
| Kurtosis | (0.36) |
Willow Biosciences Backtested Returns
Willow Biosciences appears to be out of control, given 3 months investment horizon. Willow Biosciences shows Sharpe Ratio of 0.0762, which attests that the company had a 0.0762 % return per unit of risk over the last 3 months. By examining Willow Biosciences' technical indicators, you can evaluate if the expected return of 0.69% is justified by implied risk. Please utilize Willow Biosciences' Market Risk Adjusted Performance of 0.3271, downside deviation of 10.48, and Mean Deviation of 6.3 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Willow Biosciences holds a performance score of 6. The firm maintains a market beta of 1.47, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Willow Biosciences will likely underperform. Please check Willow Biosciences' total risk alpha and the relationship between the value at risk and day median price , to make a quick decision on whether Willow Biosciences' historical returns will revert.
Auto-correlation | -0.13 |
Insignificant reverse predictability
Willow Biosciences has insignificant reverse predictability. Overlapping area represents the amount of predictability between Willow Biosciences time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Willow Biosciences price movement. The serial correlation of -0.13 indicates that less than 13.0% of current Willow Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.13 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Willow OTC Stock
Willow Biosciences financial ratios help investors to determine whether Willow OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.